InvestorsHub Logo
Followers 15
Posts 1314
Boards Moderated 0
Alias Born 09/11/2007

Re: None

Sunday, 07/05/2020 3:38:03 PM

Sunday, July 05, 2020 3:38:03 PM

Post# of 42472
More exposure, HGEN mentioned in a Motley Fool article dated today.

https://www.fool.com/investing/2020/07/05/is-this-under-the-radar-stock-a-better-coronavirus.aspx

It's just one sentence, but hey it's something. lol

"Catalent hasn't just attracted vaccine makers, though. The company partnered with Humanigen to support late-stage testing of lenzilumab in treating COVID-19 patients with pneumonia."